Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Will expand facility at its Stirling, UK site with new storage and warehousing capability.
September 16, 2021
By: Tim Wright
Editor-in-Chief, Contract Pharma
Symbiosis Pharmaceutical Services, a contract manufacturing organization (CMO) specializing in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, and headquartered in Stirling, UK, has successfully completed a Medicines and Healthcare products Regulatory Agency (MHRA) inspection of its newly commissioned warehouse and storage area. The company has been undertaking phased expansion to its manufacturing support capability, including the newly operational warehousing and storage facility at its Hillfoots Building, on the Stirling site. As part of the commissioning of this expansion, the MHRA, the UK Government’s regulatory authority, carried out an on-site inspection as part of Symbiosis’ existing GMP license. The inspection, completed at the end of August 2021, represents a highly successful outcome based on the inspectors’ positive feedback. The new storage and warehousing capability will be added to the existing GMP licenses held by Symbiosis for the import and manufacture of clinical and commercial medicinal products. “For the past year we have focused on upgrading our existing world class facilities, in terms of capability and scale, in preparation for continued business growth” said Colin MacKay, CEO, Symbiosis. “This new expansion phase is the latest effort in what has been a sustained investment in both the people and the organic growth of the business over the last 10 years. “By expanding our warehousing and storage facilities we are better placed to meet the increasingly varied demands of both established and emerging markets, such as cell and gene therapies. Our ability to handle the technical complexity of these products as well as the growth we have seen in this specialist market underpins our continued investment not only in infrastructure but in our regulatory and technical strength. We are proud to have successfully completed the expansion of our warehouse and storage facilities—both on time and on budget—and that the MHRA has inspected and granted us extended license to use without any concern.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !